Here’s what you should know:
1. WeissLaw, which is following standard practice after a large acquisition is announced, is attempting to file a class action suit against Envision on behalf of its stockholders.
2. The legal firm has a two-pronged argument:
An analyst set a target acquisition price of $51 per share
Envision traded at $57.40 in August 2017
3. Despite the contrarian analyst, the majority of market analysts predicted a deal in the high $40 per share range. KKR is acquiring Envision for $46 per share.
4. Envision’s board also said on record they’d accept a bid in the high $40 per share range.
More articles on improving performance:
Ophthalmology ASC acquisitions exploded in 2017: 4 key transactions in the Northeast
7 things for ASC leaders to know for Thursday — June 14, 2018
Johnson & Johnson, Aetna CEOs land among the 46 top-earning execs
